Skip to main content
Erschienen in: Journal of Interventional Cardiac Electrophysiology 1/2014

01.01.2014

Effect of periodic pacemaker optimization on left atrial reverse remodeling in long-term cardiac resynchronization therapy

verfasst von: Guangwei Pan, Zhiqiang Liu, Pengyi He, Yuchun Yang, Yuming Mu, Wei Han, Muhuyati Wulasihan

Erschienen in: Journal of Interventional Cardiac Electrophysiology | Ausgabe 1/2014

Einloggen, um Zugang zu erhalten

Abstract

Purpose

Few data exist about the effect of cardiac resynchronization therapy (CRT) on left atrial (LA) reverse remodeling and function, and whether echocardiographic (echo)-guide pacemaker optimization of atrioventricular and interventricular delays could beneficially affect LA reverse remodeling in long-term CRT therapy.

Methods

Effect of periodic pacemaker optimization on LA reverse remodeling induced by CRT was analyzed in 113 consecutive patients (mean age, 60 ± 11 years) and stratified according to periodic pacemaker optimization (group 1) and nonperiodic pacemaker optimization (group 2). Left atrial volumes index percent changes were assessed at every continuing 6-month follow-up visit. The primary endpoint was LA reverse remodeling. The secondary endpoint included left ventricular reverse remodeling and left ventricular ejection fraction.

Results

There is no significant difference of follow-up duration in subgroups (42.43 ± 18.94 months in group 1 vs 37.76 ± 20.24 months in group 2, p = 0.228). The responder’s rate of subgroups showed similar after follow-up of 12 months (60.0 vs 53.2 %, p = 0.483). After 24-month follow-up, the mean reduction of LAV index was similar in two groups (10.34 vs 7.53 %, p = 0.257). The improvement effect of LA reverse remodeling induced by CRT was sustained during 24-month follow-up to the end of current study in periodic pacemaker optimization group. The degree of LAV index percent reduction was directly correlated to periodic pacemaker optimization at end of current analysis (17.13 vs 10.35 %, p = 0.047).

Conclusions

Periodic echo-guide pacemaker optimization of atrioventricular and interventricular delays plays a positive role on LA reverse remodeling in long-term CRT therapy.
Literatur
1.
Zurück zum Zitat Abraham, W. T., Fisher, W. G., Smith, A. L., Delurgio, D. B., Leon, A. R., Loh, E., et al. (2003). Cardiac resynchronization in chronic heart failure. New England Journal of Medicine, 346, 1845–1853.CrossRef Abraham, W. T., Fisher, W. G., Smith, A. L., Delurgio, D. B., Leon, A. R., Loh, E., et al. (2003). Cardiac resynchronization in chronic heart failure. New England Journal of Medicine, 346, 1845–1853.CrossRef
2.
Zurück zum Zitat Young, J. B., Abraham, W. T., Smith, A. L., Leon, A. R., Lieberman, R., Wilkoff, B., et al. (2003). Combined cardiac resynchronization and implantable cardioversion defibrillation in advanced chronic heart failure. The MIRACLE ICD Trial. Journal of the American Medical Association, 289, 2685–2694.PubMedCrossRef Young, J. B., Abraham, W. T., Smith, A. L., Leon, A. R., Lieberman, R., Wilkoff, B., et al. (2003). Combined cardiac resynchronization and implantable cardioversion defibrillation in advanced chronic heart failure. The MIRACLE ICD Trial. Journal of the American Medical Association, 289, 2685–2694.PubMedCrossRef
3.
Zurück zum Zitat Bristow, M. R., Saxon, L. A., Boehmer, J., Krueger, S., Kass, D. A., et al. (2004). Cardiac resynchronization therapy with or without an implantable defibrillator in advanced chronic heart failure. New England Journal of Medicine, 350, 2140–2150.PubMedCrossRef Bristow, M. R., Saxon, L. A., Boehmer, J., Krueger, S., Kass, D. A., et al. (2004). Cardiac resynchronization therapy with or without an implantable defibrillator in advanced chronic heart failure. New England Journal of Medicine, 350, 2140–2150.PubMedCrossRef
4.
Zurück zum Zitat Cleland, J. G., Daubert, J. C., Erdmann, E., Freemantle, N., Gras, D., Kappenberger, L., et al. (2005). The effect of cardiac resynchronization on morbidity and mortality in heart failure. New England Journal of Medicine, 352, 1539–1549.PubMedCrossRef Cleland, J. G., Daubert, J. C., Erdmann, E., Freemantle, N., Gras, D., Kappenberger, L., et al. (2005). The effect of cardiac resynchronization on morbidity and mortality in heart failure. New England Journal of Medicine, 352, 1539–1549.PubMedCrossRef
5.
Zurück zum Zitat Saxon, L. A., Boehmer, J. P., Hummel, J., Kacet, S., De Marco, T., Naccarelli, G., et al. (1999). Biventricular pacing in patients with congestive heart failure: two prospective randomized trials. The VIGOR CHF and VENTAK CHF Investigators. The American Journal of Cardiology, 83, 120D–123D.PubMedCrossRef Saxon, L. A., Boehmer, J. P., Hummel, J., Kacet, S., De Marco, T., Naccarelli, G., et al. (1999). Biventricular pacing in patients with congestive heart failure: two prospective randomized trials. The VIGOR CHF and VENTAK CHF Investigators. The American Journal of Cardiology, 83, 120D–123D.PubMedCrossRef
6.
Zurück zum Zitat Adelstein, E. C., Shalaby, A., & Saba, S. (2010). Response to cardiac resynchronization therapy in patients with heart failure and renal insufficiency. Pacing and Clinical Electrophysiology, 33, 850–859.PubMedCrossRef Adelstein, E. C., Shalaby, A., & Saba, S. (2010). Response to cardiac resynchronization therapy in patients with heart failure and renal insufficiency. Pacing and Clinical Electrophysiology, 33, 850–859.PubMedCrossRef
7.
Zurück zum Zitat Bleeker, G. B., Schalij, M. J., Van der Wall, E. E., & Bax, J. J. (2006). Postero-lateral scar tissue resulting in non-response to cardiac resynchronization therapy. Journal of Cardiovascular Electrophysiology, 17, 899–901.PubMedCrossRef Bleeker, G. B., Schalij, M. J., Van der Wall, E. E., & Bax, J. J. (2006). Postero-lateral scar tissue resulting in non-response to cardiac resynchronization therapy. Journal of Cardiovascular Electrophysiology, 17, 899–901.PubMedCrossRef
8.
Zurück zum Zitat Ansalone, G., Giannantoni, P., Ricci, R., Trambaiolo, P., Fedele, F., & Santini, M. (2002). Doppler myocardial imaging to evaluate the effectiveness of pacing sites in patients receiving myocardial imaging to evaluate the effectiveness of pacing sites in patients receiving biventricular pacing. Journal of the American College of Cardiology, 39, 489–499.PubMedCrossRef Ansalone, G., Giannantoni, P., Ricci, R., Trambaiolo, P., Fedele, F., & Santini, M. (2002). Doppler myocardial imaging to evaluate the effectiveness of pacing sites in patients receiving myocardial imaging to evaluate the effectiveness of pacing sites in patients receiving biventricular pacing. Journal of the American College of Cardiology, 39, 489–499.PubMedCrossRef
9.
Zurück zum Zitat Delnoy PP., Ritter P., Naegele H., Orazi S., Szwed H., Zupan I., et al. (2013). Association between frequent cardiac resynchronization therapy optimization and long-term clinical response: a post hoc analysis of the Clinical Evaluation on Advanced Resynchronization (CLEAR) pilot study. Europace, 15, 1174–1181. Delnoy PP., Ritter P., Naegele H., Orazi S., Szwed H., Zupan I., et al. (2013). Association between frequent cardiac resynchronization therapy optimization and long-term clinical response: a post hoc analysis of the Clinical Evaluation on Advanced Resynchronization (CLEAR) pilot study. Europace, 15, 1174–1181.
10.
Zurück zum Zitat Du Bois, D., & Du Bois, E. F. (1989). A formula to estimate the approximate surface area if height and weight be known. 1916. Nutrition, 5, 303–311.PubMed Du Bois, D., & Du Bois, E. F. (1989). A formula to estimate the approximate surface area if height and weight be known. 1916. Nutrition, 5, 303–311.PubMed
11.
Zurück zum Zitat Barold, S. S., Ilercil, A., & Herweg, B. (2008). Echocardiographic optimization of the atrioventricular and interventricular intervals during cardiac resynchronization. Europace, 10, iii88–iii95.PubMedCrossRef Barold, S. S., Ilercil, A., & Herweg, B. (2008). Echocardiographic optimization of the atrioventricular and interventricular intervals during cardiac resynchronization. Europace, 10, iii88–iii95.PubMedCrossRef
12.
Zurück zum Zitat Bhan, A., Kapetanakis, S., & Monaghan, M. J. (2008). Optimization of cardiac resynchronization therapy. Echocardiography, 25, 1031–1039.PubMedCrossRef Bhan, A., Kapetanakis, S., & Monaghan, M. J. (2008). Optimization of cardiac resynchronization therapy. Echocardiography, 25, 1031–1039.PubMedCrossRef
13.
Zurück zum Zitat Stanton, T., Hawkins, N. M., Hogg, K. J., Goodfield, N. E., Petrie, M. C., & McMurray, J. J. (2008). How should we optimize cardiac resynchronization therapy? European Heart Journal, 29, 2458–2472.PubMedCrossRef Stanton, T., Hawkins, N. M., Hogg, K. J., Goodfield, N. E., Petrie, M. C., & McMurray, J. J. (2008). How should we optimize cardiac resynchronization therapy? European Heart Journal, 29, 2458–2472.PubMedCrossRef
14.
Zurück zum Zitat Ypenburg, C., Van De Veire, N., Westenberg, J. J., Bleeker, G. B., Marsan, N. A., Henneman, M. M., et al. (2008). Noninvasive imaging in cardiac resynchronization therapy—Part 2: follow-up and optimization of settings. Pacing and Clinical Electrophysiology, 31, 1628–1639.PubMedCrossRef Ypenburg, C., Van De Veire, N., Westenberg, J. J., Bleeker, G. B., Marsan, N. A., Henneman, M. M., et al. (2008). Noninvasive imaging in cardiac resynchronization therapy—Part 2: follow-up and optimization of settings. Pacing and Clinical Electrophysiology, 31, 1628–1639.PubMedCrossRef
15.
Zurück zum Zitat Taha, N., Zhang, J., Ranjan, R., Daneshvar, S., Castillo, E., Guillen, E., et al. (2010). Biventricular pacemaker optimization guided by comprehensive echocardiography—Preliminary observations regarding the effects on systolic and diastolic ventricular function and third heart sound. Journal of the American Society of Echocardiography, 23, 857–866.PubMedCrossRef Taha, N., Zhang, J., Ranjan, R., Daneshvar, S., Castillo, E., Guillen, E., et al. (2010). Biventricular pacemaker optimization guided by comprehensive echocardiography—Preliminary observations regarding the effects on systolic and diastolic ventricular function and third heart sound. Journal of the American Society of Echocardiography, 23, 857–866.PubMedCrossRef
16.
Zurück zum Zitat Vidal, B., Sitges, M., Marigliano, A., Delgado, V., Díaz-Infante, E., Azqueta, M., et al. (2007). Optimizing the programation of cardiac resynchronization therapy devices in patients with heart failure and left bundle branch block. The American Journal of Cardiology, 100, 1002–1006.PubMedCrossRef Vidal, B., Sitges, M., Marigliano, A., Delgado, V., Díaz-Infante, E., Azqueta, M., et al. (2007). Optimizing the programation of cardiac resynchronization therapy devices in patients with heart failure and left bundle branch block. The American Journal of Cardiology, 100, 1002–1006.PubMedCrossRef
17.
Zurück zum Zitat León, A. R., Abraham, W. T., Brozena, S., Daubert, J. P., Fisher, W. G., Gurley, J. C., et al. (2005). Cardiac resynchronization with sequential biventricular pacing for the treatment of moderate-to-severe heart failure. Journal of the American College of Cardiology, 46, 2298–2304.PubMedCrossRef León, A. R., Abraham, W. T., Brozena, S., Daubert, J. P., Fisher, W. G., Gurley, J. C., et al. (2005). Cardiac resynchronization with sequential biventricular pacing for the treatment of moderate-to-severe heart failure. Journal of the American College of Cardiology, 46, 2298–2304.PubMedCrossRef
18.
Zurück zum Zitat Malagoli A., Rossi L., Franchi F., Piepoli MF., Malavasi V., Casali E., et al. Effect of cardiac resynchronization therapy on left atrial reverse remodeling: Role of echocardiographic AV delay optimization. International Journal Cardiology, 167, 1456–1460. Malagoli A., Rossi L., Franchi F., Piepoli MF., Malavasi V., Casali E., et al. Effect of cardiac resynchronization therapy on left atrial reverse remodeling: Role of echocardiographic AV delay optimization. International Journal Cardiology, 167, 1456–1460.
19.
Zurück zum Zitat Brenyo, A., Link, M. S., Barsheshet, A., Moss, A. J., Zareba, W., Wang, P. J., et al. (2011). Cardiac resynchronization therapy reduces left atrial volume and the risk of atrial tachyarrhythmias in MADIT-CRT (Multicenter Automatic Defibrillator Implantation Trial with Cardiac Resynchronization Therapy). Journal of the American College of Cardiology, 58(16), 1682–1689.PubMedCrossRef Brenyo, A., Link, M. S., Barsheshet, A., Moss, A. J., Zareba, W., Wang, P. J., et al. (2011). Cardiac resynchronization therapy reduces left atrial volume and the risk of atrial tachyarrhythmias in MADIT-CRT (Multicenter Automatic Defibrillator Implantation Trial with Cardiac Resynchronization Therapy). Journal of the American College of Cardiology, 58(16), 1682–1689.PubMedCrossRef
20.
Zurück zum Zitat Maisel, W. H., & Stevenson, L. W. (2003). Atrial fibrillation in heart failure: Epidemiology, pathophysiology, and rationale for therapy. The American Journal of Cardiology, 91, 2D–8D.PubMedCrossRef Maisel, W. H., & Stevenson, L. W. (2003). Atrial fibrillation in heart failure: Epidemiology, pathophysiology, and rationale for therapy. The American Journal of Cardiology, 91, 2D–8D.PubMedCrossRef
21.
Zurück zum Zitat Steinberg, J. S. (2006). Desperately seeking a randomized clinical trial of resynchronization therapy for patients with heart failure and atrial fibrillation. Journal of the American College of Cardiology, 48, 744–746.PubMedCrossRef Steinberg, J. S. (2006). Desperately seeking a randomized clinical trial of resynchronization therapy for patients with heart failure and atrial fibrillation. Journal of the American College of Cardiology, 48, 744–746.PubMedCrossRef
22.
Zurück zum Zitat Dries, D. L., Exner, D. V., Gersh, B. J., Domanski, M. J., Waclawiw, M. A., & Stevenson, L. W. (1998). Atrial fibrillation is associated with an increased risk for mortality and heart failure progression in patients with asymptomatic and symptomatic left ventricular systolic dysfunction: a retrospective analysis of the SOLVD trials. Studies of left ventricular dysfunction. Journal of the American College of Cardiology, 32, 695–703.PubMedCrossRef Dries, D. L., Exner, D. V., Gersh, B. J., Domanski, M. J., Waclawiw, M. A., & Stevenson, L. W. (1998). Atrial fibrillation is associated with an increased risk for mortality and heart failure progression in patients with asymptomatic and symptomatic left ventricular systolic dysfunction: a retrospective analysis of the SOLVD trials. Studies of left ventricular dysfunction. Journal of the American College of Cardiology, 32, 695–703.PubMedCrossRef
23.
Zurück zum Zitat Wang, T. J., Larson, M. G., Levy, D., Vasan, R. S., Leip, E. P., Wolf, P. A., et al. (2003). Temporal relations of atrial fibrillation and congestive heart failure and their joint influence on mortality: The Framingham Heart Study. Circulation, 107, 2920–2925.PubMedCrossRef Wang, T. J., Larson, M. G., Levy, D., Vasan, R. S., Leip, E. P., Wolf, P. A., et al. (2003). Temporal relations of atrial fibrillation and congestive heart failure and their joint influence on mortality: The Framingham Heart Study. Circulation, 107, 2920–2925.PubMedCrossRef
24.
Zurück zum Zitat Kutyifa, V., Kloppe, A., Zareba, W., Solomon, S. D., McNitt, S., Polonsky, S., et al. (2013). The influence of left ventricular ejection fraction on the effectiveness of cardiac resynchronization therapy: MADIT-CRT (Multicenter Automatic Defibrillator Implantation Trial With Cardiac Resynchronization Therapy). Journal of the American College of Cardiology, 61(9), 936–944.PubMedCrossRef Kutyifa, V., Kloppe, A., Zareba, W., Solomon, S. D., McNitt, S., Polonsky, S., et al. (2013). The influence of left ventricular ejection fraction on the effectiveness of cardiac resynchronization therapy: MADIT-CRT (Multicenter Automatic Defibrillator Implantation Trial With Cardiac Resynchronization Therapy). Journal of the American College of Cardiology, 61(9), 936–944.PubMedCrossRef
25.
Zurück zum Zitat Linde C., Gold MR., Abraham WT., St John Sutton M., Ghio S., Cerkvenik J., Daubert C. (2013). Long-term impact of cardiac resynchronization therapy in mild heart failure: 5-year results from the resynchronization reverses Remodeling in Systolic left ventricular dysfunction (REVERSE) study. European Heart Journal, 34(33), 2592–2599. Linde C., Gold MR., Abraham WT., St John Sutton M., Ghio S., Cerkvenik J., Daubert C. (2013). Long-term impact of cardiac resynchronization therapy in mild heart failure: 5-year results from the resynchronization reverses Remodeling in Systolic left ventricular dysfunction (REVERSE) study. European Heart Journal, 34(33), 2592–2599.
26.
Zurück zum Zitat O’Donnell, D., Nadurata, V., Hamer, A., Kertes, P., & Mohamed, U. (2005). Long-term variations in optimal programming of cardiac resynchronization therapy devices. Pacing and Clinical Electrophysiology, 28(Suppl 1), S24–S26.PubMedCrossRef O’Donnell, D., Nadurata, V., Hamer, A., Kertes, P., & Mohamed, U. (2005). Long-term variations in optimal programming of cardiac resynchronization therapy devices. Pacing and Clinical Electrophysiology, 28(Suppl 1), S24–S26.PubMedCrossRef
27.
Zurück zum Zitat Ritter, P., Delnoy, P. P., Padeletti, L., Lunati, M., Naegele, H., Borri-Brunetto, A., et al. (2012). Randomized pilot study of optimization of cardiac resynchronization therapy in sinus rhythm patients using a peak endocardial acceleration sensor vs. standard methods. Europace, 14, 1324–1333.PubMedCrossRef Ritter, P., Delnoy, P. P., Padeletti, L., Lunati, M., Naegele, H., Borri-Brunetto, A., et al. (2012). Randomized pilot study of optimization of cardiac resynchronization therapy in sinus rhythm patients using a peak endocardial acceleration sensor vs. standard methods. Europace, 14, 1324–1333.PubMedCrossRef
Metadaten
Titel
Effect of periodic pacemaker optimization on left atrial reverse remodeling in long-term cardiac resynchronization therapy
verfasst von
Guangwei Pan
Zhiqiang Liu
Pengyi He
Yuchun Yang
Yuming Mu
Wei Han
Muhuyati Wulasihan
Publikationsdatum
01.01.2014
Verlag
Springer US
Erschienen in
Journal of Interventional Cardiac Electrophysiology / Ausgabe 1/2014
Print ISSN: 1383-875X
Elektronische ISSN: 1572-8595
DOI
https://doi.org/10.1007/s10840-013-9833-3

Weitere Artikel der Ausgabe 1/2014

Journal of Interventional Cardiac Electrophysiology 1/2014 Zur Ausgabe

Screening-Mammografie offenbart erhöhtes Herz-Kreislauf-Risiko

26.04.2024 Mammografie Nachrichten

Routinemäßige Mammografien helfen, Brustkrebs frühzeitig zu erkennen. Anhand der Röntgenuntersuchung lassen sich aber auch kardiovaskuläre Risikopatientinnen identifizieren. Als zuverlässiger Anhaltspunkt gilt die Verkalkung der Brustarterien.

Niedriger diastolischer Blutdruck erhöht Risiko für schwere kardiovaskuläre Komplikationen

25.04.2024 Hypotonie Nachrichten

Wenn unter einer medikamentösen Hochdrucktherapie der diastolische Blutdruck in den Keller geht, steigt das Risiko für schwere kardiovaskuläre Ereignisse: Darauf deutet eine Sekundäranalyse der SPRINT-Studie hin.

Therapiestart mit Blutdrucksenkern erhöht Frakturrisiko

25.04.2024 Hypertonie Nachrichten

Beginnen ältere Männer im Pflegeheim eine Antihypertensiva-Therapie, dann ist die Frakturrate in den folgenden 30 Tagen mehr als verdoppelt. Besonders häufig stürzen Demenzkranke und Männer, die erstmals Blutdrucksenker nehmen. Dafür spricht eine Analyse unter US-Veteranen.

Adipositas-Medikament auch gegen Schlafapnoe wirksam

24.04.2024 Adipositas Nachrichten

Der als Antidiabetikum sowie zum Gewichtsmanagement zugelassene Wirkstoff Tirzepatid hat in Studien bei adipösen Patienten auch schlafbezogene Atmungsstörungen deutlich reduziert, informiert der Hersteller in einer Vorab-Meldung zum Studienausgang.

Update Kardiologie

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert.